铁剂联合促红细胞生成素治疗血液透析患者贫血的疗效和护理观察被引量：3

下载PDF

导出

摘要目的:观察铁剂联合促红细胞生成素治疗血液透析患者贫血的疗效和护理分析。方法:回顾采用铁剂联合促红细胞生成素治疗血液透析贫血患者60例临床治疗及护理资料,并进行比较。结果:经过治疗和护理,60例患者血红蛋白(Hb)、红细胞(RBC)、红细胞压积(HCT)、血清铁蛋白均较治疗前升高,各指标具体数值分别为(97.98±16.95)g/L、(3.36±0.61)×1012/L、(31.1±4.2)%、(672.40±184.30)g/L,与治疗前比较差异有统计学意义(P<0.05),且无明显不良反应。结论:应用右旋糖酐铁联合促红细胞生成素治疗肾性贫血效果良好,同时予以相应的护理,能降低不良反应并有效地提高患者的生存质量。

作者张丽

机构地区郑州市中医院肾内科

出处《中国医药导报》 CAS 2011年第9期96-97,共2页 China Medical Herald

关键词血液透析贫血铁剂促红细胞生成素护理

分类号 R969 [医药卫生—药理学]

引文网络
相关文献

参考文献5

1李德天,李旭,王艳秋,刘大军,杨旭,周光宇,苏雪松,何平.静脉用右旋糖酐氢氧化铁注射液治疗肾性贫血疗效观察[J].中国实用内科杂志,2005,25(8):735-736. 被引量：20
2包丽媛,王荣,仲娜,刘洪梅,潘艳梅.老年血液透析患者动静脉内瘘的护理28例[J].实用护理杂志,2003,19(5):11-11. 被引量：75
3臧玉萍,孙虹.中药灌肠治疗慢性肾功能衰竭的临床观察及护理[J].青岛医药卫生,2005,37(2):115-115. 被引量：2
4王莉,叶长宁,王芳,何强,李贵森.静脉补铁和口服补铁对肾性贫血的治疗比较[J].四川医学,2002,23(11):1111-1113. 被引量：10
5李振勤,高菊.对肾性贫血慢性肾功能衰竭患者补铁疗效的临床观察[J].中国现代医生,2007,45(08S):59-59. 被引量：5

二级参考文献14

1佐中孜秋中隆.透析疗法[M].北京：军事医学出版社,1999.90-92.
2朱有华梅长林.尿毒症预防与康复[M].上海：第二军医大学出版社,1999.144.
3[1]Teehan B, et al. Hematologic and physiologic studies during correction of anemia with recombinant human erythropoietin in predialysis patients. Trans-plant Proc, 1996,212:63
4[2]Harnett JD, et al. Congestive heart failure in dialysis patients:prevalence, in-cidence,prognosis and risk factors. Kidney Int, 1995,47:884
5[3]Vanholder R, et al. Contributing factors to the inhibition of phagocytosis inhemodialyzed patients. Kidney Int, 1993,44:208
6[4]Lowrie EG, et al. The relative contribution of measured variables to death riskamong hemodialysis patients, in Friedman E A: Death on hemo dialysis: pre-ventable or inevitable? Boston, MA, Kluwer academic Publisher, 1994,121
7[5]US Renal Date System: The USRD Dialysis Morbidity and Mortality Study(Wave 1). in National Instiutes of Health, National Institute Diabetes and Digestive and Kidney Disease: US renal Date System 1996 Annual Date Report.Bethesda, MD, 1996,45
8[6]Mizuguchi T, et al. Serum transferrin receptor level as an index of the response to erythropoietin therapy for anemia in pre-dialysis patients with chronic renal failure. Nippon Jinzo Gakkai Shi, 1997 Jul,39(5):497
9Macougall IC,Tucker B,Thompson J,et al.A randomized conreolled study of iron supplementation in patients treated with erythropoietin.Kidney Int,1996,50(5):1694-1699.
10Sloand JA,Shelly MA,Feigin A,et al.A double-blind,placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome.Am J Kidney Dis,2004,43(4):663-670.